• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 变体的基因组监测及其在发病机制中的作用,重点关注印度 COVID-19 的第二波疫情。

Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India.

机构信息

CSIR-Indian Institute of Chemical Biology (IICB), Calcutta, WB, 700032, India.

IICB-Translational Research Unit of Excellence, Cancer Biology and Inflammatory Disorder, Salt Lake, WB, 700091, India.

出版信息

Sci Rep. 2023 Mar 22;13(1):4692. doi: 10.1038/s41598-023-30815-5.

DOI:10.1038/s41598-023-30815-5
PMID:36949118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10031706/
Abstract

India had witnessed unprecedented surge in SARS-CoV-2 infections and its dire consequences during the second wave of COVID-19, but the detailed report of the epidemiological based spatiotemporal incidences of the disease is missing. In the manuscript, we have applied various statistical approaches (correlation, hierarchical clustering) to decipher the pattern of pathogenesis of the circulating VoCs responsible for surge in the incidences. B.1.617.1 (Kappa) was the predominant VoC during the early phase of the second wave, whereas, Delta (B.1.617.2) or Delta-like (AY.x) VoC constitutes majority ([Formula: see text]%) of the cases during the peak of the second wave. The correlation plot of Delta/Delta-like lineage demonstrates inverse correlation with other lineages including B.1.617.1, B.1.1.7, B.1, B.1.36.29 and B.1.36. The spatiotemporal analysis shows that most of the Indian states were affected during the peak of the second wave due to the Delta surge, and fall under the same cluster. The second cluster populated mostly by north-eastern states and the islands of India were minimally affected. The presence of signature mutations (T478K, D950N, E156G) along with L452K, D614G and P681R within the spike protein of Delta or Delta-like might cause elevation in the host cell attachment, increased transmission and altered antigenicity which in due course of time has replaced the other circulating variants.The timely assessment of new VoCs including Delta-like will provide a rationale for updating the diagnostic, vaccine development by medical industries and decision making by various agencies including government, educational institutions, and corporate industries.

摘要

印度在第二波 COVID-19 期间经历了 SARS-CoV-2 感染的空前激增及其可怕后果,但缺乏基于疾病的流行病学时空发生率的详细报告。在本文中,我们应用了各种统计方法(相关性、层次聚类)来破译负责发病率激增的循环变异体的发病模式。B.1.617.1(Kappa)是第二波早期的主要变异体,而 Delta(B.1.617.2)或 Delta 样(AY.x)变异体在第二波高峰期构成了大多数病例([Formula: see text]%)。Delta/Delta 样谱系的相关图显示与其他谱系(包括 B.1.617.1、B.1.1.7、B.1、B.1.36.29 和 B.1.36)呈负相关。时空分析表明,由于 Delta 激增,大多数印度邦在第二波高峰期受到影响,并归入同一集群。第二集群主要由东北部各州和印度各岛组成,受影响最小。Delta 或 Delta 样中的刺突蛋白中存在特征突变(T478K、D950N、E156G)以及 L452K、D614G 和 P681R,可能导致宿主细胞附着增加、传播增加和抗原性改变,从而在适当的时候取代了其他循环变体。及时评估包括 Delta 样在内的新变异体将为医疗行业更新诊断、疫苗开发以及包括政府、教育机构和企业行业在内的各个机构的决策提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/76ee4183cfbc/41598_2023_30815_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/bb6c014713be/41598_2023_30815_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/fb8230cc6032/41598_2023_30815_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/a79699c6ea01/41598_2023_30815_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/c6bef6f51d50/41598_2023_30815_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/76ee4183cfbc/41598_2023_30815_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/bb6c014713be/41598_2023_30815_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/fb8230cc6032/41598_2023_30815_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/a79699c6ea01/41598_2023_30815_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/c6bef6f51d50/41598_2023_30815_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1738/10033908/76ee4183cfbc/41598_2023_30815_Fig5_HTML.jpg

相似文献

1
Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India.SARS-CoV-2 变体的基因组监测及其在发病机制中的作用,重点关注印度 COVID-19 的第二波疫情。
Sci Rep. 2023 Mar 22;13(1):4692. doi: 10.1038/s41598-023-30815-5.
2
The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.博戈地区及周边地区循环的 SARS-CoV-2 谱系动态反映了印度尼西亚 COVID-19 第一波和第二波期间的变异转移。
PeerJ. 2022 Mar 22;10:e13132. doi: 10.7717/peerj.13132. eCollection 2022.
3
Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India.基因组特征分析揭示了 SARS-CoV-2 德尔塔变异株 B.1.617.2 在印度恰蒂斯加尔邦 COVID-19 大流行第二波中的致病作用。
Microb Pathog. 2022 Mar;164:105404. doi: 10.1016/j.micpath.2022.105404. Epub 2022 Jan 19.
4
Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India.基因组测序揭示了印度北方邦东部令人担忧的新冠病毒变异株传播的复杂情况。
Front Med (Lausanne). 2022 Jan 7;8:781287. doi: 10.3389/fmed.2021.781287. eCollection 2021.
5
Genetic sequencing detected the SARS-CoV-2 delta variant in wastewater a month prior to the first COVID-19 case in Ahmedabad (India).基因测序在印度艾哈迈达巴德首例 COVID-19 病例出现前一个月就在废水中检测到了 SARS-CoV-2 德尔塔变异株。
Environ Pollut. 2022 Oct 1;310:119757. doi: 10.1016/j.envpol.2022.119757. Epub 2022 Jul 16.
6
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
7
Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India.德尔塔变异株 SARS-CoV-2 感染在印度第二波疫情中的儿科病例。
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 1):1060-1068. doi: 10.1016/j.jmii.2022.06.001. Epub 2022 Jul 2.
8
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.印度马哈拉施特拉邦第二波新冠疫情中出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白突变,L452R、T478K、E484Q和P681R
Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542.
9
Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India.相对 Kappa 变异株的巩固发生在印度第二波 COVID-19 大规模疫情之前。
Genes (Basel). 2021 Nov 16;12(11):1803. doi: 10.3390/genes12111803.
10
Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study.印度全基因组视角下 SARS-CoV-2 疫情传播的研究。
Virus Res. 2022 Jan 15;308:198642. doi: 10.1016/j.virusres.2021.198642. Epub 2021 Nov 22.

引用本文的文献

1
Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.印度成年人对 AZD1222/Covishield 和 BV152/Covaxin COVID-19 疫苗的体液和细胞免疫反应。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2410579. doi: 10.1080/21645515.2024.2410579. Epub 2024 Oct 21.
2
Wastewater Surveillance of SARS-CoV-2 in Zambia: An Early Warning Tool.赞比亚的 SARS-CoV-2 污水监测:预警工具。
Int J Mol Sci. 2024 Aug 14;25(16):8839. doi: 10.3390/ijms25168839.
3
Genomic surveillance of SARS-CoV-2 in North Africa: 4 years of GISAID data sharing.

本文引用的文献

1
Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India.印度高度突变 BA 变异株的基因组特征、系统发育评估和时空动态研究。
Indian J Med Microbiol. 2023 May-Jun;43:66-72. doi: 10.1016/j.ijmmb.2022.10.006. Epub 2022 Nov 15.
2
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.自然感染和疫苗诱导的免疫对未来感染 SARS-CoV-2 的持久性。
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2204336119. doi: 10.1073/pnas.2204336119. Epub 2022 Jul 15.
3
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
北非地区严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基因组监测:4年的全球流感数据共享倡议(GISAID)数据分享
IJID Reg. 2024 Mar 19;11:100356. doi: 10.1016/j.ijregi.2024.100356. eCollection 2024 Jun.
4
A comprehensive profile of SARS-CoV-2 variants spreading during the COVID-19 pandemic: a genomic characterization study from Chhattisgarh State, India.COVID-19 大流行期间传播的 SARS-CoV-2 变体的综合特征:来自印度恰蒂斯加尔邦的基因组特征研究。
Arch Microbiol. 2024 Jan 18;206(2):68. doi: 10.1007/s00203-023-03807-2.
5
Overview of immunological & virological factors driving the evolution & global spread of SARS-CoV-2 variants.免疫和病毒学因素概述:推动 SARS-CoV-2 变异株的进化和全球传播。
Indian J Med Res. 2023 Sep;158(3):257-268. doi: 10.4103/ijmr.ijmr_2591_22.
6
Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India.印度安得拉邦有症状病例中分离的 SARS-CoV-2 变异株的突变分析。
Viruses. 2023 Jul 29;15(8):1656. doi: 10.3390/v15081656.
7
Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India.印度高度突变 BA 变异株的基因组特征、系统发育评估和时空动态研究。
Indian J Med Microbiol. 2023 May-Jun;43:66-72. doi: 10.1016/j.ijmmb.2022.10.006. Epub 2022 Nov 15.
全球首例 COVID-19 疫苗接种一年的影响:一项数学建模研究。
Lancet Infect Dis. 2022 Sep;22(9):1293-1302. doi: 10.1016/S1473-3099(22)00320-6. Epub 2022 Jun 23.
4
Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)德尔塔变异株(B.1.617.2)在新冠疫情第二波激增中的影响以及疫苗在应对当前大流行中的效力
Hum Vaccin Immunother. 2021 Nov 2;17(11):4126-4127. doi: 10.1080/21645515.2021.1963601. Epub 2021 Sep 2.
5
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.印度马哈拉施特拉邦第二波新冠疫情中出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白突变,L452R、T478K、E484Q和P681R
Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542.
6
Genomic surveillance to combat COVID-19: challenges and opportunities.基因组监测应对 COVID-19:挑战与机遇。
Lancet Microbe. 2021 Sep;2(9):e481-e484. doi: 10.1016/S2666-5247(21)00121-X. Epub 2021 Jul 27.
7
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
8
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
9
Implications of the second wave of COVID-19 in India.新冠疫情第二波在印度的影响
Lancet Respir Med. 2021 Sep;9(9):e93-e94. doi: 10.1016/S2213-2600(21)00312-X. Epub 2021 Jun 30.
10
SARS-CoV-2 variants of concern are emerging in India.令人担忧的新冠病毒变异毒株正在印度出现。
Nat Med. 2021 Jul;27(7):1131-1133. doi: 10.1038/s41591-021-01397-4.